Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 6 | 0 | 0 | 6 |
Luciferase | 6 | 0 | 0 | 6 |
RAR-related orphan receptor gamma | 6 | 0 | 0 | 6 |
retinoid X nuclear receptor alpha | 5 | 0 | 0 | 5 |
G | 6 | 0 | 0 | 6 |
peroxisome proliferator activated receptor gamma | 9 | 0 | 0 | 9 |
euchromatic histone-lysine N-methyltransferase 2 | 10 | 0 | 0 | 10 |
thyroid stimulating hormone receptor | 5 | 0 | 0 | 5 |
chromobox protein homolog 1 | 4 | 0 | 0 | 4 |
parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 3 | 0 | 0 | 3 |
geminin | 6 | 0 | 0 | 6 |
muscleblind-like protein 1 isoform 1 | 5 | 0 | 0 | 5 |
Interferon beta | 9 | 0 | 0 | 9 |
HLA class I histocompatibility antigen, B alpha chain | 6 | 0 | 0 | 6 |
Guanine nucleotide-binding protein G | 1 | 0 | 0 | 1 |
Inositol hexakisphosphate kinase 1 | 6 | 0 | 0 | 6 |
cytochrome P450 2C9, partial | 6 | 0 | 0 | 6 |
Chain A, Heat Shock Protein 90 | 0 | 0 | 1 | 1 |
Chain A, GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATE AMIDOTRANSFERASE | 0 | 0 | 1 | 1 |
Chain B, GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATE AMIDOTRANSFERASE | 0 | 0 | 1 | 1 |
Chain A, EOSINOPHIL-DERIVED NEUROTOXIN | 0 | 1 | 0 | 1 |
Chain A, EOSINOPHIL-DERIVED NEUROTOXIN | 0 | 1 | 0 | 1 |
Chain A, EOSINOPHIL-DERIVED NEUROTOXIN | 0 | 1 | 0 | 1 |
Chain A, Myosin Ie Heavy Chain | 0 | 0 | 1 | 1 |
Chain A, Preprotein translocase secA | 0 | 0 | 1 | 1 |
Chain A, Ribonuclease pancreatic | 0 | 1 | 0 | 1 |
Chain A, Ribonuclease pancreatic | 0 | 1 | 0 | 1 |
Chain A, Ribonuclease pancreatic | 0 | 1 | 0 | 1 |
Chain A, Ribonuclease pancreatic | 0 | 1 | 0 | 1 |
Chain A, Ribonuclease pancreatic | 0 | 1 | 0 | 1 |
Chain A, Phosphoribosylformylglycinamidine synthase | 0 | 1 | 0 | 1 |
Chain A, nucleoside diphosphate kinase A | 0 | 0 | 1 | 1 |
Chain B, nucleoside diphosphate kinase A | 0 | 0 | 1 | 1 |
Chain D, DNA polymerase III subunit gamma | 0 | 0 | 1 | 1 |
Chain D, DNA polymerase III subunit gamma | 0 | 0 | 1 | 1 |
Chain A [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 3 | 0 | 0 | 1 | 1 |
Chain A [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 3 | 0 | 0 | 1 | 1 |
Chain A, Kinesin-like protein KIF11 | 0 | 1 | 0 | 1 |
regulator of G-protein signaling 4 | 5 | 0 | 0 | 5 |
HPr kinase/phosphorylase | 0 | 0 | 1 | 1 |
Mitogen-activated protein kinase kinase kinase 7 | 0 | 0 | 1 | 1 |
ATP-dependent molecular chaperone HSP82 | 0 | 0 | 0 | 1 |
Heat shock protein HSP 90-alpha | 0 | 1 | 1 | 3 |
Heat shock protein HSP 90-beta | 0 | 1 | 1 | 3 |
2-dehydropantoate 2-reductase | 0 | 1 | 1 | 2 |
Heat shock 70 kDa protein 1A | 0 | 1 | 1 | 2 |
Endoplasmic reticulum chaperone BiP | 0 | 0 | 1 | 1 |
Heat shock cognate 71 kDa protein | 0 | 0 | 1 | 1 |
Pyruvate kinase PKM | 0 | 0 | 0 | 1 |
Pyruvate kinase PKLR | 0 | 0 | 0 | 1 |
Endoplasmin | 0 | 0 | 0 | 1 |
Heat shock cognate 71 kDa protein | 0 | 0 | 1 | 1 |
5'-nucleotidase | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 0 | 1 | 1 |
Delta-type opioid receptor | 0 | 0 | 1 | 1 |
Kappa-type opioid receptor | 0 | 0 | 1 | 1 |
Endoplasmin | 0 | 1 | 1 | 2 |
P2Y purinoceptor 2 | 0 | 0 | 1 | 1 |
Phosphatidylinositol 4-kinase alpha | 0 | 2 | 0 | 2 |
P2X purinoceptor 1 | 0 | 0 | 1 | 1 |
P2Y purinoceptor 1 | 0 | 0 | 1 | 1 |
P2Y purinoceptor 1 | 0 | 0 | 1 | 1 |
P2X purinoceptor 1 | 0 | 0 | 1 | 1 |
P2X purinoceptor 4 | 0 | 0 | 1 | 1 |
P2X purinoceptor 5 | 0 | 0 | 1 | 1 |
P2X purinoceptor 6 | 0 | 0 | 1 | 1 |
P2X purinoceptor 3 | 0 | 0 | 1 | 1 |
Inositol monophosphatase 1 | 4 | 0 | 0 | 4 |
Heat shock protein 75 kDa, mitochondrial | 0 | 1 | 0 | 1 |
P2Y purinoceptor 6 | 0 | 0 | 1 | 1 |
Phosphatidylinositol 4-kinase type 2-beta | 0 | 2 | 0 | 2 |
P2Y purinoceptor 11 | 0 | 0 | 1 | 1 |
Phosphatidylinositol 4-kinase type 2-alpha | 0 | 2 | 0 | 2 |
P2Y purinoceptor 12 | 0 | 0 | 1 | 1 |
Sensor protein kinase WalK | 0 | 1 | 0 | 1 |
Phosphatidylinositol 4-kinase beta | 0 | 2 | 0 | 2 |
P2X purinoceptor 2 | 0 | 0 | 1 | 1 |
TDP1 protein | 7 | 0 | 0 | 7 |
AR protein | 10 | 0 | 0 | 10 |
glucocorticoid receptor [Homo sapiens] | 6 | 0 | 0 | 6 |
estrogen nuclear receptor alpha | 14 | 0 | 0 | 14 |
ATP-binding cassette sub-family C member 3 | 0 | 6 | 0 | 6 |
Multidrug resistance-associated protein 4 | 0 | 6 | 0 | 7 |
Bile salt export pump | 0 | 11 | 0 | 11 |
Cellular tumor antigen p53 | 7 | 0 | 0 | 7 |
Thromboxane-A synthase | 0 | 1 | 0 | 1 |
Prostaglandin E2 receptor EP3 subtype | 0 | 1 | 0 | 1 |
Prostaglandin E2 receptor EP4 subtype | 0 | 1 | 1 | 2 |
Prostaglandin E2 receptor EP1 subtype | 0 | 1 | 0 | 1 |
Prostacyclin receptor | 0 | 1 | 1 | 2 |
Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 1 | 1 |
Solute carrier organic anion transporter family member 2A1 | 0 | 0 | 0 | 1 |
Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 1 | 1 |
Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 1 | 1 |
Prostaglandin E2 receptor EP2 subtype | 0 | 1 | 1 | 2 |
Canalicular multispecific organic anion transporter 1 | 0 | 6 | 0 | 6 |
Solute carrier organic anion transporter family member 2A1 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 2B1 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 3A1 | 0 | 0 | 0 | 1 |
Chain A, Coagulation factor X (EC 3.4.21.6) (Stuart factor) (Stuart-Prower factor) | 0 | 1 | 0 | 1 |
EWS/FLI fusion protein | 7 | 0 | 0 | 7 |
Coagulation factor X | 0 | 1 | 0 | 1 |
Prothrombin | 0 | 4 | 0 | 4 |
Coagulation factor X | 0 | 6 | 0 | 6 |
Trypsin-1 | 0 | 2 | 0 | 2 |
Trypsin-2 | 0 | 2 | 0 | 2 |
Trypsin-3 | 0 | 2 | 0 | 2 |
Spike glycoprotein | 6 | 0 | 0 | 6 |
Dihydroorotate dehydrogenase | 0 | 2 | 0 | 2 |
Protease | 0 | 1 | 0 | 1 |
USP1 protein, partial | 5 | 0 | 0 | 5 |
Microtubule-associated protein tau | 4 | 0 | 0 | 4 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 8 | 0 | 0 | 8 |
retinoic acid nuclear receptor alpha variant 1 | 6 | 0 | 0 | 6 |
estrogen-related nuclear receptor alpha | 10 | 0 | 0 | 10 |
activating transcription factor 6 | 7 | 0 | 0 | 7 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 4 | 0 | 0 | 4 |
heat shock protein beta-1 | 3 | 0 | 0 | 3 |
importin subunit beta-1 isoform 1 | 2 | 0 | 0 | 2 |
snurportin-1 | 2 | 0 | 0 | 2 |
GTP-binding nuclear protein Ran isoform 1 | 2 | 0 | 0 | 2 |
lamin isoform A-delta10 | 6 | 0 | 0 | 6 |
Rap guanine nucleotide exchange factor 3 | 3 | 0 | 0 | 3 |
Glutathione S-transferase P | 0 | 1 | 0 | 1 |
Alpha-tocopherol transfer protein | 0 | 0 | 1 | 1 |
cytochrome P450 2D6 | 3 | 0 | 0 | 3 |
Solute carrier family 22 member 2 | 0 | 2 | 0 | 2 |
Plasminogen | 0 | 1 | 0 | 1 |
Coagulation factor XII | 0 | 2 | 0 | 2 |
Tissue-type plasminogen activator | 0 | 1 | 0 | 1 |
Vitamin K-dependent protein C | 0 | 1 | 0 | 1 |
Serine protease hepsin | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M1 | 0 | 1 | 0 | 1 |
Ribosyldihydronicotinamide dehydrogenase [quinone] | 0 | 2 | 0 | 2 |
Multidrug and toxin extrusion protein 2 | 0 | 2 | 0 | 2 |
Multidrug and toxin extrusion protein 1 | 0 | 2 | 0 | 2 |
nuclear receptor subfamily 1, group I, member 3 | 4 | 0 | 0 | 4 |
Chain A, Beta-lactamase | 5 | 0 | 0 | 5 |
Chain A, JmjC domain-containing histone demethylation protein 3A | 2 | 0 | 0 | 2 |
acetylcholinesterase | 5 | 0 | 0 | 5 |
ATAD5 protein, partial | 4 | 0 | 0 | 4 |
PPM1D protein | 3 | 0 | 0 | 3 |
GLI family zinc finger 3 | 7 | 0 | 0 | 7 |
aryl hydrocarbon receptor | 3 | 0 | 0 | 3 |
Histone H2A.x | 5 | 0 | 0 | 5 |
DNA polymerase beta | 3 | 0 | 0 | 3 |
flap endonuclease 1 | 1 | 0 | 0 | 1 |
histone-lysine N-methyltransferase 2A isoform 2 precursor | 2 | 0 | 0 | 2 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 5 | 0 | 0 | 5 |
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 3 | 0 | 0 | 3 |
DNA polymerase eta isoform 1 | 2 | 0 | 0 | 2 |
DNA polymerase iota isoform a (long) | 5 | 0 | 0 | 5 |
DNA polymerase kappa isoform 1 | 4 | 0 | 0 | 4 |
histone acetyltransferase KAT2A isoform 1 | 6 | 0 | 0 | 6 |
Inhibitor of nuclear factor kappa-B kinase subunit beta | 0 | 1 | 0 | 1 |
Lysine-specific histone demethylase 1A | 0 | 3 | 0 | 3 |
Aurora kinase B | 0 | 1 | 0 | 1 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 3 | 0 | 0 | 3 |
Chain A, Breast cancer type 1 susceptibility protein | 1 | 0 | 0 | 1 |
Chain A, HADH2 protein | 3 | 0 | 0 | 3 |
Chain B, HADH2 protein | 3 | 0 | 0 | 3 |
Chain A, 2-oxoglutarate Oxygenase | 3 | 0 | 0 | 3 |
Chain A, Ferritin light chain | 3 | 0 | 0 | 3 |
acid sphingomyelinase | 1 | 0 | 0 | 1 |
thioredoxin reductase | 6 | 0 | 0 | 6 |
RGS12 | 1 | 0 | 0 | 1 |
90-kda heat shock protein beta HSP90 beta, partial | 0 | 1 | 0 | 1 |
hypoxia-inducible factor 1 alpha subunit | 3 | 0 | 0 | 3 |
SMAD family member 2 | 2 | 0 | 0 | 2 |
Fumarate hydratase | 3 | 0 | 0 | 3 |
NFKB1 protein, partial | 3 | 0 | 0 | 3 |
SMAD family member 3 | 2 | 0 | 0 | 2 |
Thrombopoietin | 2 | 0 | 0 | 2 |
Smad3 | 2 | 0 | 0 | 2 |
DNA polymerase III, partial | 1 | 0 | 0 | 1 |
aldehyde dehydrogenase 1 family, member A1 | 5 | 0 | 0 | 5 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 2 | 0 | 0 | 2 |
thyroid stimulating hormone receptor | 4 | 0 | 0 | 4 |
estrogen receptor 2 (ER beta) | 1 | 0 | 0 | 1 |
progesterone receptor | 5 | 0 | 0 | 5 |
isocitrate dehydrogenase 1, partial | 1 | 0 | 0 | 1 |
nonstructural protein 1 | 2 | 0 | 0 | 2 |
LANA | 0 | 0 | 0 | 1 |
farnesoid X nuclear receptor | 2 | 0 | 0 | 2 |
pregnane X nuclear receptor | 5 | 0 | 0 | 5 |
NPYLR7B | 0 | 0 | 1 | 1 |
polyprotein | 3 | 0 | 0 | 3 |
67.9K protein | 1 | 0 | 0 | 1 |
bromodomain adjacent to zinc finger domain 2B | 4 | 0 | 0 | 4 |
peroxisome proliferator-activated receptor delta | 2 | 0 | 0 | 2 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 5 | 0 | 0 | 5 |
IDH1 | 2 | 0 | 0 | 2 |
thyrotropin-releasing hormone receptor | 3 | 0 | 0 | 3 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 4 | 0 | 0 | 4 |
serine-protein kinase ATM isoform a | 1 | 0 | 0 | 1 |
Bloom syndrome protein isoform 1 | 3 | 0 | 0 | 3 |
cytochrome P450 2D6 isoform 1 | 3 | 0 | 0 | 3 |
lysosomal alpha-glucosidase preproprotein | 3 | 0 | 0 | 3 |
peripheral myelin protein 22 isoform 1 | 2 | 0 | 0 | 2 |
cytochrome P450 2C19 precursor | 2 | 0 | 0 | 2 |
cytochrome P450 2C9 precursor | 3 | 0 | 0 | 3 |
D(1A) dopamine receptor | 2 | 0 | 0 | 2 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 2 | 0 | 0 | 2 |
thyroid hormone receptor beta isoform a | 3 | 0 | 0 | 3 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 2 | 0 | 0 | 3 |
potassium voltage-gated channel subfamily H member 2 isoform d | 2 | 0 | 0 | 2 |
thyroid hormone receptor beta isoform 2 | 4 | 0 | 0 | 4 |
guanine nucleotide-binding protein G(i) subunit alpha-1 isoform 1 | 1 | 0 | 0 | 1 |
ubiquitin carboxyl-terminal hydrolase 2 isoform a | 4 | 0 | 0 | 4 |
serine/threonine-protein kinase PLK1 | 1 | 0 | 0 | 1 |
eyes absent homolog 2 isoform a | 2 | 0 | 0 | 2 |
heat shock protein HSP 90-alpha isoform 2 | 0 | 1 | 0 | 1 |
tumor susceptibility gene 101 protein | 1 | 0 | 0 | 1 |
nuclear receptor ROR-gamma isoform 1 | 2 | 0 | 0 | 2 |
peripheral myelin protein 22 | 3 | 0 | 0 | 3 |
survival motor neuron protein isoform d | 5 | 0 | 0 | 5 |
cytochrome P450 3A4 isoform 1 | 3 | 0 | 0 | 3 |
caspase-1 isoform alpha precursor | 1 | 0 | 0 | 1 |
muscarinic acetylcholine receptor M1 | 4 | 0 | 0 | 4 |
lethal factor (plasmid) | 1 | 0 | 0 | 1 |
DNA dC->dU-editing enzyme APOBEC-3F isoform a | 1 | 0 | 0 | 1 |
kelch-like ECH-associated protein 1 | 0 | 0 | 0 | 2 |
neuropeptide S receptor isoform A | 2 | 0 | 0 | 2 |
cGMP-dependent 3',5'-cyclic phosphodiesterase | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit pi | 3 | 0 | 0 | 3 |
Solute carrier family 22 member 1 | 0 | 3 | 0 | 3 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 1 | 0 | 0 | 1 |
Multidrug resistance-associated protein 5 | 0 | 1 | 0 | 1 |
Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | 0 | 1 | 0 | 1 |
High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A | 0 | 3 | 0 | 3 |
cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 3 | 0 | 3 |
3',5'-cyclic-AMP phosphodiesterase | 0 | 2 | 0 | 2 |
Voltage-dependent calcium channel gamma-2 subunit | 3 | 0 | 0 | 3 |
ATP-dependent translocase ABCB1 | 0 | 3 | 1 | 11 |
Neuronal acetylcholine receptor subunit alpha-4 | 1 | 0 | 0 | 1 |
Neuronal acetylcholine receptor subunit beta-2 | 1 | 0 | 0 | 1 |
Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-1 | 3 | 0 | 0 | 3 |
Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit delta | 3 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 3 | 0 | 0 | 3 |
Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | 0 | 1 | 0 | 1 |
Glutamate receptor 2 | 3 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 3 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 3 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 3 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 3 | 0 | 0 | 3 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 3 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 3 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 3 | 0 | 0 | 3 |
Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta | 0 | 1 | 0 | 1 |
Histamine H2 receptor | 3 | 0 | 0 | 3 |
Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha' | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | 0 | 2 | 0 | 2 |
Caspase-7 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 3 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit beta-3 | 3 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit beta-2 | 3 | 0 | 0 | 3 |
Disintegrin and metalloproteinase domain-containing protein 17 | 3 | 0 | 0 | 3 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 2 | 0 | 2 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 2 | 0 | 2 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4C | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 3 | 0 | 3 |
TAR DNA-binding protein 43 | 2 | 0 | 0 | 2 |
cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 0 | 3 | 0 | 3 |
High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A | 0 | 1 | 0 | 1 |
Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 2 | 0 | 2 |
cGMP-inhibited 3',5'-cyclic phosphodiesterase A | 0 | 4 | 0 | 4 |
Exopolyphosphatase PRUNE1 | 0 | 1 | 0 | 1 |
Rap guanine nucleotide exchange factor 4 | 1 | 0 | 0 | 1 |
GABA theta subunit | 3 | 0 | 0 | 3 |
ATPase family AAA domain-containing protein 5 | 1 | 0 | 0 | 1 |
Ataxin-2 | 2 | 0 | 0 | 2 |
Equilibrative nucleoside transporter 1 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit epsilon | 3 | 0 | 0 | 3 |
Single-stranded DNA cytosine deaminase | 1 | 0 | 0 | 1 |
Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 7B | 0 | 1 | 0 | 1 |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 2 | 1 | 3 |
Phosphodiesterase | 0 | 2 | 0 | 2 |
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 0 | 2 | 0 | 3 |
Chain A, Putative fructose-1,6-bisphosphate aldolase | 4 | 0 | 0 | 4 |
Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 1 | 0 | 0 | 1 |
Genome polyprotein | 0 | 2 | 1 | 3 |
chaperonin-containing TCP-1 beta subunit homolog | 1 | 0 | 0 | 1 |
phosphopantetheinyl transferase | 4 | 0 | 0 | 4 |
GLS protein | 4 | 0 | 0 | 4 |
thioredoxin glutathione reductase | 3 | 0 | 0 | 3 |
hypothetical protein, conserved | 1 | 0 | 0 | 1 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 3 | 0 | 0 | 3 |
vitamin D3 receptor isoform VDRA | 3 | 0 | 0 | 3 |
lethal(3)malignant brain tumor-like protein 1 isoform I | 1 | 0 | 0 | 1 |
relaxin receptor 1 isoform 1 | 2 | 0 | 0 | 2 |
Flavin reductase (NADPH) | 0 | 0 | 1 | 1 |
ATP-dependent phosphofructokinase | 4 | 0 | 0 | 4 |
large T antigen | 0 | 1 | 0 | 1 |
Neuraminidase | 0 | 3 | 0 | 3 |
carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform 1 | 0 | 1 | 0 | 1 |
Calmodulin-1 | 0 | 1 | 0 | 1 |
Alpha-2B adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-2C adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-2A adrenergic receptor | 0 | 1 | 0 | 1 |
3-oxo-5-alpha-steroid 4-dehydrogenase 1 | 0 | 1 | 0 | 1 |
Substance-P receptor | 0 | 2 | 0 | 2 |
3-oxo-5-alpha-steroid 4-dehydrogenase 2 | 0 | 1 | 0 | 1 |
Nischarin | 0 | 1 | 0 | 1 |
Substance-K receptor | 0 | 2 | 0 | 2 |
Heparanase | 0 | 0 | 1 | 1 |
Chain A, Purine-nucleoside Phosphorylase | 0 | 1 | 0 | 1 |
Chain C, Xanthine dehydrogenase/oxidase | 0 | 0 | 1 | 1 |
Hypoxanthine-guanine phosphoribosyltransferase | 0 | 0 | 0 | 1 |
Purine nucleoside phosphorylase | 0 | 0 | 1 | 2 |
Chain A, ADENOSINE DEAMINASE | 0 | 1 | 0 | 1 |
Chain A, ADENOSINE DEAMINASE | 0 | 1 | 0 | 1 |
Chain A, Membrane lipoprotein tmpC | 0 | 0 | 1 | 1 |
Chain A, Membrane lipoprotein tmpC | 0 | 0 | 1 | 1 |
Chain A, Membrane lipoprotein tmpC | 0 | 0 | 1 | 1 |
glycogen synthase kinase-3 beta isoform 1 | 0 | 0 | 2 | 2 |
Purine nucleoside phosphorylase | 0 | 0 | 0 | 1 |
Adenosylhomocysteinase | 0 | 1 | 0 | 2 |
Adenosine deaminase | 0 | 1 | 0 | 1 |
histone deacetylase 9 isoform 3 | 1 | 0 | 0 | 1 |
Type II pantothenate kinase | 0 | 0 | 0 | 1 |
Type III pantothenate kinase | 0 | 0 | 0 | 1 |
Chain A, cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 0 | 1 | 0 | 1 |
glp-1 receptor, partial | 2 | 0 | 0 | 2 |
15-lipoxygenase, partial | 1 | 0 | 0 | 1 |
hexokinase-4 isoform 1 | 1 | 0 | 0 | 1 |
polyunsaturated fatty acid lipoxygenase ALOX12 | 1 | 0 | 0 | 1 |
atrial natriuretic peptide receptor 1 precursor | 1 | 0 | 0 | 1 |
glucokinase regulatory protein | 1 | 0 | 0 | 1 |
mitogen-activated protein kinase 1 | 3 | 0 | 0 | 3 |
atrial natriuretic peptide receptor 2 precursor | 1 | 0 | 0 | 1 |
ras-related protein Rab-9A | 1 | 0 | 0 | 1 |
Vascular endothelial growth factor receptor 1 | 0 | 1 | 0 | 1 |
Acetylcholinesterase | 0 | 3 | 0 | 3 |
Cytochrome P450 2C19 | 0 | 1 | 0 | 1 |
Serine hydroxymethyltransferase, mitochondrial | 0 | 1 | 0 | 1 |
Vascular endothelial growth factor receptor 3 | 0 | 1 | 0 | 1 |
Vascular endothelial growth factor receptor 2 | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 2 | 0 | 2 |
CREB-binding protein | 1 | 0 | 0 | 1 |
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 0 | 2 | 0 | 2 |
endonuclease IV | 1 | 0 | 0 | 1 |
dopamine D1 receptor | 1 | 0 | 0 | 1 |
arylsulfatase A | 1 | 0 | 0 | 1 |
vasopressin V1b receptor | 1 | 0 | 0 | 1 |
Tumor necrosis factor | 0 | 1 | 0 | 1 |
Cholinesterase | 0 | 1 | 0 | 1 |
Adenosine receptor A2b | 0 | 1 | 0 | 1 |
Chitotriosidase-1 | 0 | 2 | 1 | 3 |
Endochitinase B1 | 0 | 2 | 1 | 3 |
Gag-Pol polyprotein | 0 | 1 | 0 | 1 |
Cytochrome P450 2D6 | 0 | 1 | 0 | 1 |
Gag-Pol polyprotein | 0 | 1 | 0 | 1 |
Protease | 0 | 3 | 0 | 3 |
pregnane X receptor | 1 | 0 | 0 | 1 |
Estrogen receptor 1 | 0 | 1 | 0 | 1 |
Parkin | 1 | 0 | 0 | 1 |
fMet-Leu-Phe receptor | 0 | 1 | 0 | 1 |
M-phase phosphoprotein 8 | 1 | 0 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Cytochrome P450 2C9 | 0 | 3 | 0 | 3 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Nicotinate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Cyclooxygenase-2 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 8 | 0 | 1 | 0 | 1 |
Chain A, Activated Factor Xa Heavy Chain | 0 | 1 | 0 | 1 |
Suppressor of tumorigenicity 14 protein | 0 | 1 | 0 | 1 |
Polyphenol oxidase 2 | 0 | 1 | 0 | 1 |
L-lactate dehydrogenase A chain | 0 | 1 | 0 | 1 |
Chymotrypsinogen A | 0 | 1 | 0 | 1 |
Albumin | 0 | 1 | 0 | 1 |
Neuraminidase | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
Cytochrome P450 3A4 | 0 | 2 | 0 | 2 |
Alpha-2A adrenergic receptor | 0 | 3 | 0 | 3 |
Sialidase | 0 | 1 | 0 | 1 |
Cystic fibrosis transmembrane conductance regulator | 0 | 0 | 1 | 1 |
Alpha-2C adrenergic receptor | 0 | 1 | 0 | 1 |
Dipeptidyl peptidase 4 | 0 | 1 | 0 | 1 |
Bifunctional epoxide hydrolase 2 | 0 | 1 | 0 | 1 |
Xanthine dehydrogenase/oxidase | 0 | 1 | 0 | 1 |
Prolyl endopeptidase | 0 | 1 | 0 | 1 |
Mitogen-activated protein kinase 10 | 0 | 1 | 0 | 1 |
Mitogen-activated protein kinase 14 | 0 | 1 | 0 | 1 |
Neuromedin-U receptor 2 | 0 | 0 | 1 | 1 |
glucocerebrosidase | 1 | 0 | 0 | 1 |
huntingtin isoform 2 | 1 | 0 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 1 | 0 | 1 |
Bile salt export pump | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 4 | 0 | 2 | 0 | 2 |
Albumin | 0 | 0 | 2 | 2 |
Glycoprotein | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M2 | 0 | 0 | 1 | 1 |
ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
Cytochrome P450 2C8 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1A | 0 | 2 | 0 | 2 |
ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 2 |
Catechol O-methyltransferase | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily A member 3 | 0 | 1 | 0 | 1 |
Histamine H2 receptor | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2A | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2C | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 1B | 0 | 2 | 0 | 2 |
Sodium-dependent serotonin transporter | 0 | 2 | 0 | 2 |
Delta-type opioid receptor | 0 | 1 | 0 | 1 |
Multidrug resistance-associated protein 1 | 0 | 2 | 1 | 4 |
Mu-type opioid receptor | 0 | 1 | 0 | 1 |
D(3) dopamine receptor | 0 | 2 | 0 | 2 |
Kappa-type opioid receptor | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2B | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
Cytochrome P450 2J2 | 0 | 1 | 0 | 1 |
D(2) dopamine receptor | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
Sodium channel protein type 5 subunit alpha | 0 | 1 | 0 | 1 |
Chloroquine resistance transporter | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1B1 | 0 | 2 | 0 | 2 |
Albumin | 0 | 0 | 1 | 1 |
Proprotein convertase subtilisin/kexin type 7 | 0 | 1 | 0 | 1 |
Vitamin K epoxide reductase complex subunit 1-like protein 1 | 0 | 1 | 0 | 1 |
Vitamin K epoxide reductase complex subunit 1 | 0 | 1 | 0 | 1 |
Vitamin K epoxide reductase complex subunit 1-like protein 1 | 0 | 1 | 0 | 1 |
Vitamin K epoxide reductase complex subunit 1 | 0 | 2 | 0 | 2 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |